Inhibition of Cyclooxygenase-2 Improves Cardiac Function Following Long-Term Preservation

Journal of Surgical Research

Volumn 135, Issue 2, 2006, Pages 380-384

  Oshima, Kiyohiro ^a   Takeyoshi, Izumi ^a   Tsutsumi, Hirofumi ^a   Mohara, Jun ^a   Ohki, Shigeru ^a   Koike, Norimasa ^a   Nameki, Taro ^a   Matsumoto, Koshi ^b   Morishita, Yasuo ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NIPPON MEDICAL SCHOOL MUSASHI KOSUGI HOSPITAL   (Japan)

Author keywords

COX 2; heart preservation; heart transplantation; ischemia reperfusion injury

Indexed keywords

4' ACETYL 2' (2,4 DIFLUOROPHENOXY)METHANESULFONANILIDE; CYCLOOXYGENASE 2; DOPAMINE; GLUCOSE; INSULIN; POTASSIUM; UNIVERSITY OF WISCONSIN SOLUTION;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; CORONARY BLOOD VESSEL; CRYOPRESERVATION; DOG; DRUG EFFICACY; ENZYME INHIBITION; HEART ARREST; HEART ATRIUM PRESSURE; HEART FUNCTION; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART OUTPUT; HEART PRESERVATION; HEART TRANSPLANTATION; HEMODYNAMIC PARAMETERS; IMMUNOHISTOCHEMISTRY; NONHUMAN; ORTHOTOPIC TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION; REPERFUSION INJURY; STAINING; STATISTICAL SIGNIFICANCE;

ADENOSINE; ALLOPURINOL; ANILIDES; ANIMALS; BLOOD PRESSURE; CYCLOOXYGENASE 2 INHIBITORS; DOGS; GLUTATHIONE; HEART FUNCTION TESTS; HEART TRANSPLANTATION; INSULIN; MYOCARDIAL REPERFUSION INJURY; ORGAN PRESERVATION; ORGAN PRESERVATION SOLUTIONS; RAFFINOSE; VENTRICULAR FUNCTION, LEFT;

EID: 33748768449     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2006.03.044     Document Type: Article

References (24)

1. Hertz M.I., Boucek M.M., Deng M.C., et al. The registry of the International Society for Heart and Lung Transplantation: introduction to the 2004 annual reports. J Heart Lung Transplant 23 (2004) 789
2. Smith W.L. Prostanoid biosynthesis and mechanisms of action. Am J Physiol 263 (1992) F181
3. Mitchell J.A., Larkin S., and Williams T.J. Cyclooxygenase-2: regulation and relevance in inflammation. Biochem Pharmacol 50 (1995) 1535
4. Yang X., Ma N., Szabolcs M.J., et al. Upregulation of COX-2 during cardiac allograft rejection. Circulation 101 (2000) 430
5. Ma N., Szabolcs M.J., Sun J., et al. The effect of selective inhibition of cyclooxygenase (COX)-2 on acute cardiac allograft rejection. Transplantation 74 (2002) 1528
6. Nakamura K., Tsuji K., Konishi N., et al. Studies on anti-inflammatory agents. III. Synthesis and pharmacological properties of metabolites of 4′-acetyl-2′-(2,4-difluorophenoxy) methanesulfonanilide (FK3311). Chem Pharm Bull 41 (1993) 2050
7. Littner M.R., Kazmi G.M., and Lott F.D. Distribution of cyclooxygenase products with cyclooxygenase inhibition in isolated dog lung. J Appl Physiol 61 (1986) 988
8. Grossman C.J., Wiseman J., Lucas F.S., et al. Inhibition of constrictive and inducible cyclooxygenase activity in human platelets and mononuclear cells by NSAIDs and Cox 2 inhibitors. Inflamm Res 44 (1995) 253
9. Naraba H., Murakami M., Matsumoto H., et al. Segregated coupling of phospholipases A2, cyclooxygenase and terminal prostanoid synthases in different phases of prostanoid biosynthesis in rat peritoneal macrophages. J Immunol 160 (1998) 2974
10. Zamora C.A., Baron D.A., and Heffner J.E. Thromboxane contributes to pulmonary hypertension in ischemia-reperfusion lung injury. J Appl Physiol 74 (1993) 224
11. Tsuji K., Nakamura K., Konishi N., et al. Studies on anti-inflammatory agents. I. Synthesis and pharmacological properties of 2′-phenoxy-methanesulfonanilide derivatives. Chem Pharm Bull 40 (1992) 2399
12. Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87 (1996) 803
13. Matsuyama M., Nakatani T., Hase T., et al. The expression of cyclooxygenases and lipoxygenases in renal ischemia-reperfusion injury. Transplant Proc 36 (2004) 1939
14. Feitoza C.Q., Camara N.O.S., Pinheiro H.S., et al. Cyclooxygenase 1 and/or 2 blockade ameliorates the renal tissue damage triggered by ischemia and reperfusion injury. Int Immunopharmacol 5 (2004) 79
15. Takeyoshi I., Sunose Y., Iwazaki S., et al. The effect of a selective cyclooxygenase-2 inhibitor in extended liver resection with ischemia in dogs. J Surg Res 100 (2001) 25
16. Domoki F., Veltkamp R., Thrikawala N., et al. Ischemia-reperfusion rapidly increases COX-2 expression in piglet cerebral arteries. Am J Physiol 277 (1999) H1207
17. Yokoyama T., Aramaki O., Takano S., et al. Cyclooxygenase-2 inhibitor induces operational tolerance to fully allogenic cardiac grafts. Transplant Proc 34 (2002) 1405
18. Sunose Y., Takeyoshi I., Ohwada S., et al. The effect of cyclooxygenase-2 inhibitor FK3311 on ischemia-reperfusion injury in a canine total hepatic vascular exclusion model. J Am Coll Surg 192 (2001) 54
19. Sunose Y., Takeyoshi I., Tsutsumi H., et al. Effects of FK3311 on pulmonary ischemia-reperfusion injury in a canine model. J Surg Res 95 (2001) 167
20. Harada N., Okajima K., Kushimoto S., et al. Antithrombin reduces ischemia/reperfusion injury of rat liver by increasing the hepatic concentration of prostacyclin. Blood 93 (1999) 157
21. Naka Y., Roy D.K., Liao H., et al. cAMP-mediated vascular protection in an orthotopic rat lung transplant model. Insights into the mechanism of action of prostaglandin E1 to improve lung preservation. Circ Res 79 (1996) 773
22. Shinmura K., Tang X.L., Wang Y., et al. Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits. Proc Natl Acad Sci USA 97 (2000) 10197
23. Bolli R., Shinmura K., Tang X.L., et al. Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioning. Cardiovasc Res 55 (2002) 506
24. Camitta M.G.W., Gabel S.A., Chulada P., et al. Cyclooxygenase-1 and -2 knockout mice demonstrate increased cardiac ischemia/reperfusion injury but are protected by acute preconditioning. Circulation 104 (2001) 2453